Trends, Tips From 7 Years Of EPO Antibody Patent Appeals

By Alex Epstein and Jane Evenson
July 8, 2024, 4:33 PM BST

Since the first monoclonal antibody聽approval聽by the U.S. Food and Drug Administration in 1986,聽which was for聽Muromonab-CD3, these drugs have become progressively more common, frequently reaching blockbuster status. According to a March report...

Already a subscriber? Click here to view full article